FDA 510(k) clearance for the original Celluma (K152280)
ConfirmedWe looked it up in FDA's 510(k) database on 18 November 2026: 'BioPhotas Celluma3', applicant BioPhotas, Inc., decision date 2 March 2016. That clearance covers temporary relief of minor muscle and joint pain, arthritis and muscle spasm, mild to moderate inflammatory acne, and periorbital wrinkles.
Where the vendor states this











